Last Updated on October 30, 2024 by The Health Master
Drug Regulatory
Drug regulatory system of India has been making significant strides in recent years, gaining international recognition and trust.
This article delves into the key achievements and milestones of the Drugs Controller General of India (DCGI) and the Central Drugs Standard Control Organization (CDSCO) in ensuring the safety and efficacy of drugs, vaccines, and medical devices.
Global Recognition of Indian Pharmacopoeia (IP)
One of the most notable achievements is the recognition of the Indian pharmacopoeia (IP) as a standard by 11 countries worldwide.
This signifies the high quality and reliability of Indian pharmaceutical products and standards.
India’s growing reputation as a global pharmaceutical hub is further evidenced by its exports to over 200 countries.
A Flourishing Clinical Trials Landscape
India has also emerged as a preferred destination for international clinical trials.
In the past few years, the country has approved an average of 100 global clinical trials annually, attracting researchers and pharmaceutical companies from around the world.
This reflects the confidence in India’s drug regulatory framework and the growing capabilities of its research institutions.
Embracing Cutting-Edge Technologies
The DCGI and CDSCO have been proactive in adopting the latest technologies to ensure drug regulatory efficiency and safety.
They have approved innovative products such as car T cell therapy, mRNA vaccines, and software as medical devices, demonstrating their commitment to staying at the forefront of medical advancements.
Meeting International Standards for Vaccine Regulation
In a significant endorsement, the World Health Organization (WHO) recognized India’s vaccine regulatory system as meeting international standards.
The WHO-led expert team conducted a thorough evaluation of the Central Drugs Standard Control Organization (CDSCO), the National Regulatory Authority of India (NRA), and affiliated institutions.
Key Achievements of India’s Vaccine Regulatory System
- WHO Global Benchmarking Tool (GBT) Compliance: India has been declared ‘functional’ against all core regulatory functions of the WHO GBT Version VI.
- Global Vaccine Supplier: India boasts 36 major vaccine manufacturing facilities and is a major supplier of vaccines to both domestic and international markets, including 150 countries.
In conclusion, drug regulatory system of India has made substantial progress in recent years, gaining international recognition and trust.
The country’s commitment to quality, safety, and innovation has positioned it as a key player in the global pharmaceutical landscape.
As India continues to advance its regulatory framework and embrace emerging technologies, it is poised to play an even more pivotal role in ensuring access to safe and effective healthcare products worldwide.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
NPPA revises ceiling prices of these 8 Essential Drugs
DTAB’s recommendations about tackling the Antimicrobial Resistance Crisis
19th ICDRA – A Milestone: India’s Role in Global Healthcare
QR Code mandatory for all Vaccines in India to check fakes
India’s Vaccine Regulatory System Receives WHO Approval
USFDA declines to approve this drug for low blood sugar in infants
MvPI Releases Updated Medical Device Adverse Event Reporting Form
USFDA inspection concluded at Alembic Pharma with no observation
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
